Form Bio Co. Ltd. (377220) — Financial Flexibility Index
Form Bio Co. Ltd. (377220) has a Financial Flexibility Index of -0.05x as of September 2025. Free cash flow of ₩-2.09 Billion (operating CF ₩-2.57 Billion minus capex ₩472.81 Million) represents 0% of total liabilities (₩38.97 Billion). Also explore how fast is Form Bio Co. Ltd. growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Form Bio Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Form Bio Co. Ltd. across 6 annual periods. Check Form Bio Co. Ltd. PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Form Bio Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for Form Bio Co. Ltd.. For the full company profile including market capitalisation, see 377220 market cap overview.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.43x | ₩-13.81 Billion | ₩-14.70 Billion | ₩32.07 Billion | ▼ -130.3% |
| 2023 | -0.19x | ₩-4.15 Billion | ₩-20.85 Billion | ₩22.19 Billion | ▼ -108.3% |
| 2022 | 2.24x | ₩13.16 Billion | ₩-2.02 Billion | ₩5.87 Billion | ▲ +168.9% |
| 2021 | 0.83x | ₩10.00 Billion | ₩-1.17 Billion | ₩11.99 Billion | ▼ -19.9% |
| 2020 | 1.04x | ₩22.24 Billion | ₩15.61 Billion | ₩21.35 Billion | ▲ +350.6% |
| 2019 | 0.23x | ₩7.96 Billion | ₩5.68 Billion | ₩34.45 Billion | — |